U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
ANTHRAX IMMUNE GLOBULIN HUMAN
VKZ83S945Z
Possibly Marketed Outside US
First approved in 2015
General
Record Details
Names
6
Identifiers
5
Modifications
2
ANTHRAX IMMUNE GLOBULIN HUMAN
VKZ83S945Z
Possibly Marketed Outside US
First approved in 2015
General
Approval Year
2015
471
Record Details
Substance Class
Structurally Diverse
Source Materials Class
ORGANISM
Source Materials Type
HUMAN
Source Materials Parent
G0T704E6Z3
HOMO SAPIENS WHOLE
Part
BLOOD
Fraction Material Type
PROTEIN
Fraction Name
IGG
Record UNII
VKZ83S945Z
Record Status
Validated (UNII)
Record Version
7
6
5
4
3
2
1
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
ANTHRAX IMMUNE GLOBULIN HUMAN
Common Name
English
NP-015
Code
English
BACILLUS ANTHRACIS IMMUNE GLOBULIN HUMAN
Common Name
English
AIGIV
Common Name
English
ANTHRASIL
Brand Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
5
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
RXCUI
1722335
PRIMARY
FDA UNII
VKZ83S945Z
PRIMARY
DAILYMED
VKZ83S945Z
PRIMARY
LACTMED
Anthrax Immune Globulin Intravenous (Human)
PRIMARY
DRUG BANK
DB09057
PRIMARY
Showing 1 to 5 of 5 entries
Previous
1
Next
Modifications
2
Agent Modifications
Show
5
20
100
All
entries
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
Modification Process
Modification Role
Modification Type
Amount
Fragment Name
Fragment ID
IMMUNIZATION
TARGETED ANTIGEN
IMMUNOLOGICAL
mainly targeted against this protein
ANTHRAX PROTECTIVE ANTIGEN
OSR4FXO1IU
IMMUNIZATION
TARGETED ANTIGEN
IMMUNOLOGICAL
BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS
873OI62848
Showing 1 to 2 of 2 entries
Previous
1
Next
